Liposomal Bupivacaine Injection 133 mg/20 mL (6.6 mg/mL) Suppliers & Bulk Manufacturers
Available Forms: Liposomal injectable solution
Available Strengths: 133 mg/20 mL (6.6 mg/mL)
Reference Brands: EXPAREL
Category: Liposomal Drug Delivery
Liposomal bupivacaine blocks nerve signals by inhibiting sodium channels, providing prolonged local anesthesia. It reduces pain, supports faster recovery, and minimizes opioid use after surgery. Benefits include extended pain relief, improved patient comfort, and lower opioid dependency, enhancing outcomes in surgical and regional anesthesia.
Product Description:
Liposomal bupivacaine (EXPAREL) is regulated in the EU and US with dossiers demonstrating safety, efficacy, and manufacturing quality aligned with GMP standards. In the US, FDA approval involved extensive clinical validation, safety assessments, and GMP compliance. In the EU, CE marking certifies conformity with MDR standards for regional anesthesia. These formulations undergo validation, stability testing, and audits, supported by comprehensive documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective extended-release local anesthetic solutions, supporting postoperative pain management worldwide and improving patient outcomes.
Liposomal Bupivacaine Injection — third party manufacturing & bulk supply
Liposomal Bupivacaine Injection 133 mg/20 mL (6.6 mg/mL) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Liposomal Bupivacaine Injection is supplied as Liposomal injectable solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Liposomal Bupivacaine Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Liposomal Bupivacaine Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Liposomal Resveratrol Capsules
Strength:
100 mg to 500 mg per serving
Form: Capsules
Reference Brands: Epigenetics
View Details
Liposomal Morphine Injection
Strength:
10 mg/mL
Form: Injectable liposomal formulations
Reference Brands: DepoDur
View Details
Liposomal Vitamin C Softgels
Strength:
500 mg to 2000 mg per serving,
Form: Capsules or softgels
Reference Brands: LivOn Labs, Quicksilver Scientific, Dr. Mercola, NutraMedix
View Details
Cytarabine + Daunorubicin Liposomal
Strength:
44mg/ 100 ml
Form: Liposomal injectable
Reference Brands: Vyxeos
View DetailsQuick Response Guaranteed | Verified Suppliers
